Tuesday July 25th 2017

Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development

Conclusion: Our data do not support a role for circulating OPN levels as a biomarker for disease activity in a heterogeneous clinical setting, but does not rule out a potential role in the cerebrospinal fluid, in a controlled setting such as a clinical trial, or in concert with other biomarkers. (Source: Multiple Sclerosis)

Link:

Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development

Leave a Comment

More from category

12 National Patient Advocacy Organizations Urge Senate to Vote “No” on Advancing ACA Repeal, Urging
12 National Patient Advocacy Organizations Urge Senate to Vote “No” on Advancing ACA Repeal, Urging

/About-the-Society/News/12-National-Patient-Advocacy-Organizations-Urge-Se [Read More]

Low vitamin D may affect recovery of injured corneas
Low vitamin D may affect recovery of injured corneas

Injury or disease in combination with too little vitamin D can be bad for the window to your eyes. The three-layer, [Read More]

CUMC researchers capture first snapshot of key brain receptor in action
CUMC researchers capture first snapshot of key brain receptor in action

Columbia University Medical Center researchers have captured the first three-dimensional snapshots of the AMPA-subtype [Read More]

Contact Your Senators About Health Care
Contact Your Senators About Health Care

/About-the-Society/News/Contact-Your-Senators-About-Health-Care [Read More]

Paper Published on Recommendations for Speeding Research on Cell-Based Therapies for MS
Paper Published on Recommendations for Speeding Research on Cell-Based Therapies for MS

/About-the-Society/News/Paper-Published-on-Recommendations-for-Speeding-Re [Read More]